The state of South Carolina currently has 3 active clinical trials seeking participants for Crohn's Disease research studies. These trials are conducted in various cities, including Charleston, Greenville, Spartanburg and Columbia.
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
05/02/2024
Locations: Clinical Study Site, Summerville, South Carolina
Conditions: Inflammatory Bowel Diseases, Crohn's Disease
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/23/2024
Locations: Medical University of South Carolina, Charleston, South Carolina +1 locations
Conditions: Crohn's Disease
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina
Conditions: Crohn's Disease